List/Grid Pharmaceuticals Market Reports Subscribe RSS feed of category Pharmaceuticals

OpportunityAnalyzer: Dengue Vaccines – Opportunity Analysis and Forecasts to 2020
Dengue is a febrile illness caused by the dengue virus (DENV), a single-stranded flavivirus most commonly transmitted by the Aedes aegypti (A. aegypti) mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide spectrum of symptoms, including fevers, retro-orbital ...
OpportunityAnalyzer: Cystic Fibrosis – Opportunity Analysis and Forecasts to 2018 – Event-Driven Update
Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky mucus which clogs the lungs and leads to life-threatening lung infections; and obstructs pancreatic enzyme secretions that are essential for the body to break down and absorb nutrients. CF patients have a limited number of available treatment options and significant unmet needs still exist. Opportunities ...
EpiCast Report: Acute Coronary Syndrome (ACS) – Epidemiology Forecast to 2023
Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and high risks of sudden death and short-term mortality. The ACS incidence increases with age and will be a significant public health problem as the elderly population increases around the world. ACS is classified into three disease entities based on evidence ...
EpiCast Report: Graft-Versus-Host Disease – Epidemiology Forecast to 2023
Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either acute GVHD (aGVHD) or chronic GVHD (cGVHD). Both aGVHD and cGVHD commonly affect organs such as the skin, gastrointestinal (GI) ...
Global Vitamin and Provitamin Market to 2018 – Market Size, Growth, and Forecasts in Nearly 70 Countries
This is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market for vitamins and provitamins. The publication provides the market size, growth and forecasts at the global level as well as for the following countries: Argentina, Armenia, Australia, Austria, Azerbaijan, Belgium, Bolivia, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, ...
Pick’s Disease Global Clinical Trials Review, H1, 2014
GlobalData’s clinical trial report, “Pick’s Disease Global Clinical Trials Review, H1, 2014″ provides data on the Pick’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pick’s Disease It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ...
OpportunityAnalyzer: Chronic Lymphocytic Leukemia – Opportunity Analysis and Forecasts to 2018
Chronic lymphocytic leukemia (CLL), the most common form of adult leukemia, is caused by the uncontrolled proliferation of B lymphocytes (a type of white blood cell) in the bone marrow, blood and lymphoid tissues. This report focuses on the current treatment landscape, unmet needs, pipeline and commercial opportunity in the CLL market with coverage of both the first-line and relapsed/refractory settings. ...
© 2014 MarketOptimizer.org. All rights reserved.